Bio

Katja Neuer focuses on deal origination in Germany and globally with a focus on the CRO market. She has developed and leverages a very broad network in this industry since 2008. Katja Neuer is a chemist by training and studied at the RWTH Aachen University, Germany. She completed her PhD thesis at the University of Technology in Munich, Germany in the area of analytical chemistry and started her professional career more than 20 years ago in the environmental healthcare sector, with a strong focus on technical chemistry. In 2008 she joined INTERLAB, a leading central laboratory for clinical trials in Germany which was later acquired by Synlab (acquired in 2015 by Cinven). During her tenure at INTERLAB, the client base grew significantly as a result of her network. In 2011, Katja became Director of Business Development at MLM Medical Labs, a Germany based central lab with a focus on clinical trials. During her time at MLM, she built a business development team from scratch and helped grow the company from 20 employees to over 80 employees and double-digit M€ revenue. In December 2019, MLM was sold to the US based life science focused private equity fund, Great Point Partners, LLC, by Achelous Partners.